Stock 4888 STELLA PHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Stella Pharma Corporation

Equities

4888

JP3399680002

Delayed Japan Exchange
Other stock markets
 03:19:19 01/07/2024 BST 		5-day change 1st Jan Change
391 JPY +0.51% Intraday chart for Stella Pharma Corporation +0.52% +36.49%
02-13 Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 CI
2023 Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024
CI
Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024
CI
Stella Pharma Corporation Provides Earnings Guidance for the Fiscal Year Ending March 2024
CI
Stella Pharma Corporation Provides Earnings Guidance for the Full Year Ending March 31, 2023
CI
Stella Pharma Corporation announced that it has received funding from SMBC Nikko Securities Inc.
CI
Stella Pharma Corporation announced that it expects to receive funding from SMBC Nikko Securities Inc.
CI
Stella Pharma Corporation Provides Earnings Guidance for the Year Ending March 31, 2023
CI
Mizuho Securities Co., Ltd. acquired unknown minority stake in Stella Pharma Corporation from INCJ, Ltd.
CI
Sumitomo Heavy Industries, Ltd. - Notice Regarding Our First Overseas Introduction of BNCT in the Hainan Medical Tourism Pilot Zone, China
AQ
Certain Common Stock of Stella Pharma Corporation are subject to a Lock-Up Agreement Ending on 18-OCT-2021.
CI
Certain Common Stock of Stella Pharma Corporation are subject to a Lock-Up Agreement Ending on 20-JUL-2021.
CI
Stella Pharma Corporation has completed an IPO in the amount of ¥3.400044 billion.
CI
Stella Pharma Corporation has filed an IPO in the amount of ¥3.769614 billion.
CI
Stella Pharma Corporation announced that it has received ¥3.6 billion in funding from Sumitomo Heavy Industries, Ltd., Innovation Network Corporation of Japan
CI
Stella Pharma Corporation announced that it expects to receive ¥3.6 billion in funding from Sumitomo Heavy Industries, Ltd., Innovation Network Corporation of Japan
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4888 Stock
  4. News Stella Pharma Corporation